Join the CDDF community: working together to find ways to accelerate oncology drug development and deliver optimal treatment to cancer patients
The CDDF has developed a community of stakeholders who support a shared mission to facilitate debate and progress in the field of oncology drug development. Non-commercial organisations (academia, NGOs and associations), pharmaceutical companies, regulatory agencies and individuals in the community of cancer research can become part of the collaborative CDDF network. The CDDF believes that collaboration plays a crucial role in overcoming challenges in the development of cancer drugs. By establishing a multi-stakeholder network and working together constructively we can achieve our goal to increase efficiency in cancer drug development and accelerate the delivery of effective oncology treatment to patients.
We thank CDDF members and collaborators for their ongoing support.
The CDDF collaborates with representatives from regulatory authorities to access their viewpoint on drug development.
PHARMACEUTICAL INDUSTRY MEMBERS
CDDF pharmaceutical industry members provide the industry perspective on challenges to be addressed in cancer drug development.
The CDDF cooperates closely with the following organisations whose missions are in alignment with the CDDF’s.
PATIENT ADVOCACY GROUPS
The CDDF works closely with patient advocacy groups to incorporate patient perspectives into the discussion.